Wipfli Financial Advisors’s Twist Bioscience TWST Stock Holding History

Wipfli Financial Advisors’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$18K	Buy	+520	New	+$22.1K	﹤0.01%	1610

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Wipfli Financial Advisors's TWST Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Twist Bioscience (TWST) in Q3 2022: 520 shares worth $18K. The stake represents ﹤0.01% of the portfolio and ranks #1610 among its holdings.

221 funds tracked by Wall St. Rank hold TWST as of Q3 2022.

Wipfli Financial Advisors held 520 shares of Twist Bioscience worth $18K as of Q3 2022.
Twist Bioscience was a new Wipfli Financial Advisors position in Q3 2022.
Twist Bioscience made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1610 holding.
221 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.